Login to Your Account



Non-U.S. Clinical Trials & Regulatory Actions: October 2011


Monday, November 14, 2011

Company (Location)

Product

Description

Indication

Status (Date)#


AUTOIMMUNE

Human Genome Sciences Inc. (Rockville, Md.) and GlaxoSmithKline plc (London)

Benlysta

Belimumab

Lupus

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription